Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024Thanks to all who participated in Pharmacovigilance Strategy Course
At the end of April we had an intensive two days of pharmacovigilance training with focus on GVP guidelines. We hope that all participants gained new knowledge and got an insight of how system changes will affect the day-to-day pharmacovigilance operations within the pharmaceutical companies by learning from practical examples, which are based on real life situations.
Thanks to all who participated and especially to our brilliant trainer José Alberto Ayala Ortiz (M.Sc. Pharm. and M.Sc. IT) who has experience both from the Regulatory (Danish Medicines Agency), and from the Pharmaceutical Industry, where he has been responsible for Pharmacovigilance IT systems, databases and Electronic transmissions in Project Manager role.
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
September 13, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar on “Overcoming Regulatory Challenges in Azerbaijan and Georgia”
September 13, 2024
Особенности процедуры пользовательского тестирования листка-вкладыша в Казахстане
May 28, 2024
Peculiarities of PIL Readability User Testing Procedure in Kazakhstan
May 28, 2024
Требования к клиническим испытаниям при регистрации медицинских изделий в России
May 21, 2024
Clinical Trials Requirements for Medical Device Registration in Russia
May 21, 2024
Команда Inpharmatis приняла участие в конференции RAPS Euro Convergence 2024
May 10, 2024
Inpharmatis Team Participated in RAPS Euro Convergence 2024
May 10, 2024